<?xml version="1.0"?>
<?xml-stylesheet type='text/xsl' href='../../ld1.xsl'?>
<LOBBYINGDISCLOSURE1>
   <imported>N</imported>
   <pages>2</pages>
   <regType>2</regType>
   <organizationName>Thorn Run Partners</organizationName>
   <prefix></prefix>
   <firstName></firstName>
   <lastName></lastName>
   <address1>1720 Eye Street, NW</address1>
   <address2>Suite 400</address2>
   <city>Washington</city>
   <state>DC</state>
   <zip>20006</zip>
   <zipext></zipext>
   <country>USA</country>
   <principal_city></principal_city>
   <principal_state></principal_state>
   <principal_zip></principal_zip>
   <principal_zipext></principal_zipext>
   <principal_country></principal_country>
   <registrantGeneralDescription>lobbying firm</registrantGeneralDescription>
   <selfSelect>N</selfSelect>
   <clientName>Inspirion Pharmaceuticals, LLC</clientName>
   <clientAddress>233 Mount Airy Road</clientAddress>
   <clientCity>Basking Ridge</clientCity>
   <clientState>NJ</clientState>
   <clientZip>07920</clientZip>
   <clientZipExt></clientZipExt>
   <clientCountry>USA</clientCountry>
   <prinClientCity></prinClientCity>
   <prinClientState></prinClientState>
   <prinClientZip></prinClientZip>
   <prinClientZipExt></prinClientZipExt>
   <prinClientCountry></prinClientCountry>
   <clientGeneralDescription>specialty pharmaceutical company</clientGeneralDescription>
   <senateID>400534596</senateID>
   <houseID>411610056</houseID>
   <lobbyists>
      <lobbyist>
         <lobbyistFirstName>Andrew</lobbyistFirstName>
         <lobbyistLastName>Rosenberg</lobbyistLastName>
         <lobbyistSuffix></lobbyistSuffix>
         <coveredPosition>Leg Asst, Kennedy; Leg Aide, Senate HELP Comm</coveredPosition>
         <lobbyistNew>Y</lobbyistNew>
      </lobbyist>
      <lobbyist>
         <lobbyistFirstName>Alex</lobbyistFirstName>
         <lobbyistLastName>DelPizzo</lobbyistLastName>
         <lobbyistSuffix></lobbyistSuffix>
         <coveredPosition>LD/LA,Rep.Ferguson;Transp&amp;InfrastructureCmte</coveredPosition>
         <lobbyistNew>Y</lobbyistNew>
      </lobbyist>
      <lobbyist>
         <lobbyistFirstName></lobbyistFirstName>
         <lobbyistLastName></lobbyistLastName>
         <lobbyistSuffix></lobbyistSuffix>
         <coveredPosition></coveredPosition>
         <lobbyistNew>Y</lobbyistNew>
      </lobbyist>
      <lobbyist>
         <lobbyistFirstName></lobbyistFirstName>
         <lobbyistLastName></lobbyistLastName>
         <lobbyistSuffix></lobbyistSuffix>
         <coveredPosition></coveredPosition>
         <lobbyistNew>Y</lobbyistNew>
      </lobbyist>
      <lobbyist>
         <lobbyistFirstName></lobbyistFirstName>
         <lobbyistLastName></lobbyistLastName>
         <lobbyistSuffix></lobbyistSuffix>
         <coveredPosition></coveredPosition>
         <lobbyistNew>Y</lobbyistNew>
      </lobbyist>
   </lobbyists>
   <alis>
      <ali_Code>PHA</ali_Code>
      <ali_Code></ali_Code>
      <ali_Code></ali_Code>
      <ali_Code></ali_Code>
      <ali_Code></ali_Code>
      <ali_Code></ali_Code>
      <ali_Code></ali_Code>
      <ali_Code></ali_Code>
      <ali_Code></ali_Code>
   </alis>
   <specific_issues>Issues related to promoting innovation in abuse-deterrent opioids. </specific_issues>
   <affiliatedUrl></affiliatedUrl>
   <affiliatedOrgs>
      <affiliatedOrg>
         <affiliatedOrgName></affiliatedOrgName>
         <affiliatedOrgAddress></affiliatedOrgAddress>
         <affiliatedOrgCity></affiliatedOrgCity>
         <affiliatedOrgState></affiliatedOrgState>
         <affiliatedOrgZip></affiliatedOrgZip>
         <affiliatedOrgCountry></affiliatedOrgCountry>
         <affiliatedPrinOrgCity></affiliatedPrinOrgCity>
         <affiliatedPrinOrgState></affiliatedPrinOrgState>
         <affiliatedPrinOrgCountry></affiliatedPrinOrgCountry>
      </affiliatedOrg>
      <affiliatedOrg>
         <affiliatedOrgName></affiliatedOrgName>
         <affiliatedOrgAddress></affiliatedOrgAddress>
         <affiliatedOrgCity></affiliatedOrgCity>
         <affiliatedOrgState></affiliatedOrgState>
         <affiliatedOrgZip></affiliatedOrgZip>
         <affiliatedOrgCountry></affiliatedOrgCountry>
         <affiliatedPrinOrgCity></affiliatedPrinOrgCity>
         <affiliatedPrinOrgState></affiliatedPrinOrgState>
         <affiliatedPrinOrgCountry></affiliatedPrinOrgCountry>
      </affiliatedOrg>
      <affiliatedOrg>
         <affiliatedOrgName></affiliatedOrgName>
         <affiliatedOrgAddress></affiliatedOrgAddress>
         <affiliatedOrgCity></affiliatedOrgCity>
         <affiliatedOrgState></affiliatedOrgState>
         <affiliatedOrgZip></affiliatedOrgZip>
         <affiliatedOrgCountry></affiliatedOrgCountry>
         <affiliatedPrinOrgCity></affiliatedPrinOrgCity>
         <affiliatedPrinOrgState></affiliatedPrinOrgState>
         <affiliatedPrinOrgCountry></affiliatedPrinOrgCountry>
      </affiliatedOrg>
   </affiliatedOrgs>
   <foreignEntities>
      <foreignEntity>
         <name></name>
         <address></address>
         <city></city>
         <state></state>
         <country></country>
         <prinCity></prinCity>
         <prinState></prinState>
         <prinCountry></prinCountry>
         <contribution></contribution>
         <ownership_Percentage></ownership_Percentage>
      </foreignEntity>
      <foreignEntity>
         <name></name>
         <address></address>
         <city></city>
         <state></state>
         <country></country>
         <prinCity></prinCity>
         <prinState></prinState>
         <prinCountry></prinCountry>
         <contribution></contribution>
         <ownership_Percentage></ownership_Percentage>
      </foreignEntity>
   </foreignEntities>
   <reportYear>2014</reportYear>
   <reportType>RR</reportType>
   <effectiveDate>03/15/2014</effectiveDate>
   <printedName>W. Christopher Lamond, Partner</printedName>
   <signedDate>04/01/2014</signedDate>
</LOBBYINGDISCLOSURE1>